Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer

Abstract Background Although genes have been previously detected in pancreatic cancer (PC), aberrant genes that play roles in resectable pancreatic cancer should be further assessed. Methods Messenger RNA samples and clinicopathological data corrected with PC were downloaded from The Cancer Genome A...

Full description

Bibliographic Details
Main Authors: Chao Wu, Zuowei Wu, Bole Tian
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12893-020-00856-y
_version_ 1818501385938796544
author Chao Wu
Zuowei Wu
Bole Tian
author_facet Chao Wu
Zuowei Wu
Bole Tian
author_sort Chao Wu
collection DOAJ
description Abstract Background Although genes have been previously detected in pancreatic cancer (PC), aberrant genes that play roles in resectable pancreatic cancer should be further assessed. Methods Messenger RNA samples and clinicopathological data corrected with PC were downloaded from The Cancer Genome Atlas (TCGA). Resectable PC patients were randomly divided into a primary set and a validation set. Univariable Cox regression analysis, lasso-penalized Cox regression analysis, and multivariable Cox analysis were implemented to distinguish survival-related genes (SRGs). A risk score based on the SRGs was calculated by univariable Cox regression analysis. A genomic-clinical nomogram was established by integrating the risk score and clinicopathological data to predict overall survival (OS) in resectable PC. Results Five survival-related genes (AADAC, DEF8, HIST1H1C, MET, and CHFR) were significantly correlated with OS in resectable PC. The resectable PC patients, based on risk score, were sorted into a high-risk group that showed considerably unfavorable OS (p < 0.001) than the low-risk group, in both the primary set and the validation set. The concordance index (C-index) was calculated to evaluate the predictive performance of the nomogram were respectively in the primary set [0.696 (0.608–0.784)] and the validation set [0.682 (0.606–0.758)]. Additionally, gene set enrichment Analysis discovered several meaningful enriched pathways. Conclusion Our study identified five prognostic gene biomarkers for OS prediction and which facilitate postoperative molecular target therapy for the resectable PC, especially the nomic-clinical nomogram which may be used as an effective model for the postoperative OS evaluation and also an optimal therapeutic tool for the resectable PC.
first_indexed 2024-12-10T20:55:24Z
format Article
id doaj.art-fc10d0906dd444c7b082d8715561216b
institution Directory Open Access Journal
issn 1471-2482
language English
last_indexed 2024-12-10T20:55:24Z
publishDate 2020-09-01
publisher BMC
record_format Article
series BMC Surgery
spelling doaj.art-fc10d0906dd444c7b082d8715561216b2022-12-22T01:33:59ZengBMCBMC Surgery1471-24822020-09-0120111010.1186/s12893-020-00856-yFive gene signatures were identified in the prediction of overall survival in resectable pancreatic cancerChao Wu0Zuowei Wu1Bole Tian2Department of Pancreatic Surgery, West China Hospital, Sichuan UniversityDepartment of Pancreatic Surgery, West China Hospital, Sichuan UniversityDepartment of Pancreatic Surgery, West China Hospital, Sichuan UniversityAbstract Background Although genes have been previously detected in pancreatic cancer (PC), aberrant genes that play roles in resectable pancreatic cancer should be further assessed. Methods Messenger RNA samples and clinicopathological data corrected with PC were downloaded from The Cancer Genome Atlas (TCGA). Resectable PC patients were randomly divided into a primary set and a validation set. Univariable Cox regression analysis, lasso-penalized Cox regression analysis, and multivariable Cox analysis were implemented to distinguish survival-related genes (SRGs). A risk score based on the SRGs was calculated by univariable Cox regression analysis. A genomic-clinical nomogram was established by integrating the risk score and clinicopathological data to predict overall survival (OS) in resectable PC. Results Five survival-related genes (AADAC, DEF8, HIST1H1C, MET, and CHFR) were significantly correlated with OS in resectable PC. The resectable PC patients, based on risk score, were sorted into a high-risk group that showed considerably unfavorable OS (p < 0.001) than the low-risk group, in both the primary set and the validation set. The concordance index (C-index) was calculated to evaluate the predictive performance of the nomogram were respectively in the primary set [0.696 (0.608–0.784)] and the validation set [0.682 (0.606–0.758)]. Additionally, gene set enrichment Analysis discovered several meaningful enriched pathways. Conclusion Our study identified five prognostic gene biomarkers for OS prediction and which facilitate postoperative molecular target therapy for the resectable PC, especially the nomic-clinical nomogram which may be used as an effective model for the postoperative OS evaluation and also an optimal therapeutic tool for the resectable PC.http://link.springer.com/article/10.1186/s12893-020-00856-yPancreatic cancerPrognostic modelTCGABiomarkersSurvivalNomogram
spellingShingle Chao Wu
Zuowei Wu
Bole Tian
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
BMC Surgery
Pancreatic cancer
Prognostic model
TCGA
Biomarkers
Survival
Nomogram
title Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
title_full Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
title_fullStr Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
title_full_unstemmed Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
title_short Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
title_sort five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
topic Pancreatic cancer
Prognostic model
TCGA
Biomarkers
Survival
Nomogram
url http://link.springer.com/article/10.1186/s12893-020-00856-y
work_keys_str_mv AT chaowu fivegenesignatureswereidentifiedinthepredictionofoverallsurvivalinresectablepancreaticcancer
AT zuoweiwu fivegenesignatureswereidentifiedinthepredictionofoverallsurvivalinresectablepancreaticcancer
AT boletian fivegenesignatureswereidentifiedinthepredictionofoverallsurvivalinresectablepancreaticcancer